Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
2005 1
2006 1
2007 7
2008 3
2009 4
2010 2
2011 4
2012 6
2013 8
2014 11
2015 11
2016 19
2017 28
2018 28
2019 22
2020 27
2021 26
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

192 results
Results by year
Filters applied: . Clear all
Page 1
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
Balar AV, Kamat AM, Kulkarni GS, Uchio EM, Boormans JL, Roumiguié M, Krieger LEM, Singer EA, Bajorin DF, Grivas P, Seo HK, Nishiyama H, Konety BR, Li H, Nam K, Kapadia E, Frenkl T, de Wit R. Balar AV, et al. Among authors: kulkarni gs. Lancet Oncol. 2021 Jul;22(7):919-930. doi: 10.1016/S1470-2045(21)00147-9. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051177 Clinical Trial.
Reply by Authors.
Richard PO, Bashir S, Riverin BD, Alibhai SMH, Kim SJ, Ahmad A, Fleshner NE, Gupta A, Mohammed A, Zlotta AR, Kulkarni GS. Richard PO, et al. Among authors: kulkarni gs. J Urol. 2019 Aug;202(2):325. doi: 10.1097/01.JU.0000558494.56102.db. Epub 2019 Jul 8. J Urol. 2019. PMID: 31042130 No abstract available.
Radical cystectomy-what is the optimal surgical approach?
Nason GJ, Ajib K, Tan GH, Kulkarni GS. Nason GJ, et al. Among authors: kulkarni gs. Transl Androl Urol. 2020 Oct;9(5):2308-2312. doi: 10.21037/tau-20-880. Transl Androl Urol. 2020. PMID: 33209702 Free PMC article. No abstract available.
Lack of Evidence Does Not Equal Lack of Benefit: Neoadjuvant Chemotherapy and Trimodality Therapy in Selected Patients with Muscle-Invasive Bladder Cancer : In response to: Dirk Böhmer and Arne Grün. Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer.
Jiang DM, Chung P, Kulkarni GS, James ND, Sridhar SS. Jiang DM, et al. Among authors: kulkarni gs. Curr Oncol Rep. 2021 Mar 3;23(3):36. doi: 10.1007/s11912-021-01035-9. Curr Oncol Rep. 2021. PMID: 33660142 No abstract available.
Canadian Urological Association guideline: Muscle-invasive bladder cancer.
Kulkarni GS, Black PC, Sridhar SS, Kapoor A, Zlotta AR, Shayegan B, Rendon RA, Chung P, van der Kwast T, Alimohamed N, Fradet Y, Kassouf W. Kulkarni GS, et al. Can Urol Assoc J. 2019 Jan 31;13(8):230-238. doi: 10.5489/cuaj.5902. Online ahead of print. Can Urol Assoc J. 2019. PMID: 30763236 Free PMC article. No abstract available.
Standardized Reporting of Machine Learning Applications in Urology: The STREAM-URO Framework.
Kwong JCC, McLoughlin LC, Haider M, Goldenberg MG, Erdman L, Rickard M, Lorenzo AJ, Hung AJ, Farcas M, Goldenberg L, Nguan C, Braga LH, Mamdani M, Goldenberg A, Kulkarni GS. Kwong JCC, et al. Among authors: kulkarni gs. Eur Urol Focus. 2021 Jul;7(4):672-682. doi: 10.1016/j.euf.2021.07.004. Epub 2021 Aug 3. Eur Urol Focus. 2021. PMID: 34362709
192 results